Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Other growth factor receptors in Platelet-Rich Plasma (PRP) refers to a collective group of transmembrane proteins that mediate the biological effects of the various signaling molecules found within concentrated platelets [1]. PRP contains a high concentration of growth factors, including Platelet-Derived Growth Factor (PDGF), Transforming Growth Factor-beta (TGF-beta), Vascular Endothelial Growth Factor (VEGF), and Insulin-like Growth Factor (IGF) [2]. These factors bind to their respective receptors—such as PDGFR, TGFbetaR, VEGFR, and IGFR—on the surface of target cells like fibroblasts and mesenchymal stem cells [3]. These receptors are primarily receptor tyrosine kinases or serine/threonine kinases that, upon activation, trigger intracellular cascades such as the MAPK and PI3K/Akt pathways [2]. This coordinated signaling promotes essential regenerative processes including cell proliferation, chemotaxis, extracellular matrix synthesis, and angiogenesis [4]. Because PRP is a complex biological product rather than a single molecule, this target represents the integrated response of multiple receptor systems working synergistically to facilitate tissue healing [1]. It is commonly discussed in the context of regenerative medicine for treating conditions like osteoarthritis, tendon injuries, and chronic wounds [3]. Consequently, it is not considered a single therapeutic target in the traditional pharmacological sense but rather a descriptive category for the multi-receptor mechanism of PRP therapy [4]. [1] Marx RE. J Oral Maxillofac Surg. 2004. [2] Pavlovic V, et al. Open Med (Wars). 2016. [3] Etulain J. Platelets. 2018. [4] Eppley BL, et al. Plast Reconstr Surg. 2006.
Simultaneous activation of multiple cell-surface receptor pathways (e.g., PDGFR, VEGFR, FGFR) by a concentrated cocktail of endogenous growth factors to enhance tissue repair.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Other growth factor receptors in Platelet-Rich Plasma.